Positive results for anifrolumab in phase III SLE trial

被引:6
|
作者
Onuora, Sarah
机构
[1] Nature Reviews Rheumatology,
关键词
D O I
10.1038/s41584-020-0384-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:125 / 125
页数:1
相关论文
共 50 条
  • [21] EFFECTS OF ANIFROLUMAB ON RENAL DISEASE IN PATIENTS WITH SLE
    Morand, E. F.
    Furie, R.
    Tanaka, Y.
    Takeuchi, T.
    Abreu, G.
    Tummala, R.
    Lindholm, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 592 - 593
  • [22] SLE Treatment History and Anifrolumab Efficacy by Baseline Standard Therapies in Patients with SLE from 2 Phase 3 Trials
    Manzi, Susan
    Furie, Richard
    Morand, Eric
    Tanaka, Yoshiya
    Abreu, Gabriel
    Lindholm, Catharina
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3623 - 3625
  • [23] Positive Phase III Results in ANCHOR Studies in CRSwNP
    Hofmann-Assmus, Marion
    ALLERGO JOURNAL, 2025, 34 (01) : 49 - 49
  • [25] Nilotinib approved thanks to positive Phase III results
    不详
    EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (04) : 377 - 377
  • [26] Subcutaneous anifrolumab for SLE: a new step forward?
    Costedoat-Chalumeau, Nathalie
    Le Guern, Veronique
    LANCET RHEUMATOLOGY, 2021, 3 (02): : E84 - E85
  • [27] BLYS-targeted antibody shows promise in Phase III SLE trial
    Nature Reviews Drug Discovery, 2009, 8 : 688 - 688
  • [28] Positive Phase III results for Benlysta™ as lupus drug
    不详
    IMMUNOTHERAPY, 2009, 1 (05) : 729 - 729
  • [29] Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial
    Jayne, David
    Rovin, Brad
    Mysler, Eduardo
    Furie, Richard
    Houssiau, Frederic
    Trasieva, Teodora
    Knagenhjelm, Jacob
    Schwetje, Erik
    Tang, Weifeng
    Tummala, Raj
    Lindholm, Catharina
    LUPUS SCIENCE & MEDICINE, 2023, 10 (02):
  • [30] Anifrolumab Effects on Response to Influenza Vaccine in SLE
    Arriens, Cristina
    Askanase, Anca
    Machua, Wambui
    Koumpouras, Fotios
    Smith, Ken
    Guthridge, Joel
    James, Judith
    Merrill, Joan
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4916 - 4918